299 related articles for article (PubMed ID: 18669576)
1. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
[TBL] [Abstract][Full Text] [Related]
2. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
3. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
[TBL] [Abstract][Full Text] [Related]
4. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
Münch A; Bohr J; Miehlke S; Benoni C; Olesen M; Öst Å; Strandberg L; Hellström PM; Hertervig E; Armerding P; Stehlik J; Lindberg G; Björk J; Lapidus A; Löfberg R; Bonderup O; Avnström S; Rössle M; Dilger K; Mueller R; Greinwald R; Tysk C; Ström M;
Gut; 2016 Jan; 65(1):47-56. PubMed ID: 25425655
[TBL] [Abstract][Full Text] [Related]
5. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
[TBL] [Abstract][Full Text] [Related]
7. Oral budesonide therapy improves quality of life in patients with collagenous colitis.
Madisch A; Heymer P; Voss C; Wigginghaus B; Bästlein E; Bayerdörffer E; Meier E; Schimming W; Bethke B; Stolte M; Miehlke S
Int J Colorectal Dis; 2005 Jul; 20(4):312-6. PubMed ID: 15549326
[TBL] [Abstract][Full Text] [Related]
8. Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Hanauer S; Sandborn WJ; Persson A; Persson T
Aliment Pharmacol Ther; 2005 Feb; 21(4):363-71. PubMed ID: 15709986
[TBL] [Abstract][Full Text] [Related]
9. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.
Miehlke S; Heymer P; Bethke B; Bästlein E; Meier E; Bartram HP; Wilhelms G; Lehn N; Dorta G; DeLarive J; Tromm A; Bayerdörffer E; Stolte M
Gastroenterology; 2002 Oct; 123(4):978-84. PubMed ID: 12360457
[TBL] [Abstract][Full Text] [Related]
10. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis.
Bonderup OK; Hansen JB; Birket-Smith L; Vestergaard V; Teglbjaerg PS; Fallingborg J
Gut; 2003 Feb; 52(2):248-51. PubMed ID: 12524408
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
[TBL] [Abstract][Full Text] [Related]
12. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
Miehlke S; Aust D; Mihaly E; Armerding P; Böhm G; Bonderup O; Fernández-Bañares F; Kupcinskas J; Munck LK; Rehbehn KU; Nacak T; Greinwald R; Münch A;
Gastroenterology; 2018 Dec; 155(6):1795-1804.e3. PubMed ID: 30195447
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy.
Miehlke S; Hansen JB; Madisch A; Schwarz F; Kuhlisch E; Morgner A; Teglbjaerg PS; Vieth M; Aust D; Bonderup OK
Inflamm Bowel Dis; 2013 Dec; 19(13):2763-7. PubMed ID: 24216688
[TBL] [Abstract][Full Text] [Related]
16. Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial.
Münch A; Mihaly E; Nagy F; Madisch A; Kupčinskas J; Miehlke S; Bohr J; Bouma G; Guardiola J; Belloc B; Shi C; Aust D; Mohrbacher R; Greinwald R; Munck LK
United European Gastroenterol J; 2021 Sep; 9(7):837-847. PubMed ID: 34414678
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; van Assche G; Reinisch W; Colombel JF; D'Haens G; Wolf DC; Kron M; Tighe MB; Lazar A; Thakkar RB
Gastroenterology; 2012 Feb; 142(2):257-65.e1-3. PubMed ID: 22062358
[TBL] [Abstract][Full Text] [Related]
18. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis.
Lindgren S; Löfberg R; Bergholm L; Hellblom M; Carling L; Ung KA; Schiöler R; Unge P; Wallin C; Ström M; Persson T; Suhr OB
Scand J Gastroenterol; 2002 Jun; 37(6):705-10. PubMed ID: 12126250
[TBL] [Abstract][Full Text] [Related]
19. Time to remission with budesonide in collagenous colitis.
Miehlke S; Madisch A; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Jun; 21(12):1507-8; author reply 1508. PubMed ID: 15948819
[No Abstract] [Full Text] [Related]
20. Adalimumab in budesonide and methotrexate refractory collagenous colitis.
Münch A; Ignatova S; Ström M
Scand J Gastroenterol; 2012 Jan; 47(1):59-63. PubMed ID: 22149977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]